Lapinig, Garmie B.
HRN: 22-07-01 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/16/2022
CEFUROXIME 1.5GM (VIAL)
10/16/2022
10/22/2022
IV
1.5 G
Now The Q8
Second Degree Laceration, Thickly Msaf
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes